Emerging Science, NAMs, and AI

---

ToxVeritas examines the emerging methods, computational tools, and AI-enabled workflows that are influencing toxicology and regulatory science. This category is designed for professionals who want practical, balanced education on new approach methodologies, in silico toxicology, read-across, data integration, literature intelligence, knowledge management, and AI-assisted scientific workflows.

New approach methodologies can include in chemico, in vitro, ex vivo, computational, omics-based, and other non-animal or human-relevant evidence streams. Their value depends on the decision context, endpoint, biological relevance, performance characteristics, applicability domain, validation status, and transparent interpretation. These tools can strengthen an evidence package, but they do not eliminate the need for expert judgment, exposure understanding, data-quality review, or careful communication of uncertainty.

AI can accelerate literature screening, document organization, signal detection, taxonomy development, question generation, drafting support, and information retrieval. However, AI-generated outputs may be incomplete, non-reproducible, biased by input data, or wrong. ToxVeritas can help users adopt an approach in which AI assists scientific work, while accountable experts retain responsibility for verification, interpretation, and decisions.

• NAM fundamentals: Explanations of new approach methodologies, intended contexts of use, strengths, limitations, reproducibility, and relevance to different toxicological endpoints.
• Computational toxicology: Educational resources on QSAR, read-across, chemical category approaches, analogue selection, structure alerts, metabolism considerations, and applicability domain.
• Integrated evidence: How information from experimental studies, computational models, mechanistic evidence, exposure data, and human relevance may be combined in an integrated approach to testing and assessment.
• AI for scientific productivity: Practical insights on AI-assisted evidence mapping, literature triage, structured extraction, terminology normalization, summarization, traceability, and research knowledge bases.
• AI governance: Discussion of human oversight, source verification, confidential-information boundaries, version control, provenance, model limitations, privacy, validation, and documentation.
• Scientific communication: How to describe AI-supported work transparently, distinguish assistance from evidence, and avoid presenting automated output as an expert conclusion.
• Future readiness: Curated commentary on emerging methods, regulatory acceptance trends, scientific debates, standards development, and workforce skills relevant to modern toxicology.

ToxVeritas does not validate proprietary algorithms, certify AI systems for regulatory use, provide automated safety determinations, generate client-specific regulatory conclusions, or process confidential employer, client, supplier, patient, or proprietary product data through public-facing tools.